U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07435389) titled 'VENTILATION DURING SPACEFLIGHT (PHASE 2)' on Feb. 20.
Brief Summary: Space flights expose astronauts to medical risks, particularly respiratory risks, which are exacerbated in microgravity. Devices such as standard oxygen therapy and non-invasive ventilation (NIV) are used, but their performance in microgravity remains poorly studied. Parabolic flights allow these technologies to be evaluated in conditions similar to those encountered during space missions. In an initial study conducted in microgravity during a parabolic flight campaign, the T1 ventilator proved superior to the other devices tested on the test bench. However, its pe...